CORTANCYL Side Effects

6914510-6 | Interstitial Lung Disease
on Aug 05, 2010 Female patient from FRANCE , 74 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Cortancyl (View Usage). Patient experienced the following unwanted or unexpected effects: interstitial lung disease. Cortancyl dosage: . During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ), METOJECT (Dose:10 Milligram(s)/millilitre) (View Metoject Review and Metoject Label ), MABTHERA (View Mabthera Review and Mabthera Label ), VALACYCLOVIR (View Valacyclovir Review and Valacyclovir Label ), SKENAN (View Skenan Review and Skenan Label ), MORPHINE (View Morphine Review and Morphine Label ), ESOMEPRAZOLE MAGNESIUM (View Esomeprazole Magnesium Review and Esomeprazole Magnesium Label ), TRAMADOL HCL (View Tramadol Hcl Review and Tramadol Hcl Label ). Patient was hospitalized.

6257523-2 | Pancreatitis Acute
Patient was taking Cortancyl (View Usage). Patient had the following side effects: pancreatitis acute on Jun 26, 2009 from Additional patient health information: Female patient , 58 years of age, was diagnosed with prophylaxis and. Cortancyl dosage: . During the same period patient was treated with LOVENOX (View Lovenox Review and Lovenox Label ), NOROXIN (View Noroxin Review and Noroxin Label ), PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), CALCIUM WITH VITAMIN D /01233101/ (View Calcium With Vitamin D /01233101/ Review and Calcium With Vitamin D /01233101/ Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), DIFFU K (View Diffu K Review and Diffu K Label ), LASILIX /00032601/ (View Lasilix /00032601/ Review and Lasilix /00032601/ Label ), PREVISCAN /00789001/ (View Previscan /00789001/ Review and Previscan /00789001/ Label ). Patient was hospitalized.

5938973-8 | Epistaxis, Nausea, Platelet Count Decreased, Thrombocytopenia
Adverse event was reported on Oct 29, 2008 by a Male patient taking Cortancyl (View Usage) (Dosage: ) . Location: , 64 years of age, After Cortancyl was administered, patient had the following side effects: epistaxis, nausea (What is nausea?), platelet count decreased, thrombocytopenia. During the same period patient was treated with LOVENOX (View Lovenox Review and Lovenox Label ), INIPOMP /01263201/ (View Inipomp /01263201/ Review and Inipomp /01263201/ Label ), TARCEVA /01611401/ (View Tarceva /01611401/ Review and Tarceva /01611401/ Label ). Patient was hospitalized.

5918621-3 | Epistaxis, Nausea, Platelet Count Decreased, Thrombocytopenia
on Oct 07, 2008 Male patient from , 64 years of age, was treated with Cortancyl (View Usage). Patient experienced the following unwanted or unexpected effects: epistaxis, nausea (What is nausea?), platelet count decreased, thrombocytopenia. Cortancyl dosage: . During the same period patient was treated with LOVENOX (View Lovenox Review and Lovenox Label ), INIPOMP /01263201/ (View Inipomp /01263201/ Review and Inipomp /01263201/ Label ), TARCEVA /01611401/ (View Tarceva /01611401/ Review and Tarceva /01611401/ Label ). Patient was hospitalized.


5830052-3 | Echinococciasis, Respiratory Disorder
on Jul 22, 2008 Female patient from , 33 years of age, was treated with Cortancyl (View Usage). Patient had the following side effects: echinococciasis, respiratory disorder. Cortancyl dosage: . During the same period patient was treated with ARAVA (View Arava Review and Arava Label ). Patient was hospitalized.

5809089-6 | Agranulocytosis, Leukopenia, Lymphopenia
Patient was taking Cortancyl (View Usage). After Cortancyl was administered, patient had the following side effects: agranulocytosis, leukopenia, lymphopenia on Jun 30, 2008 from Additional patient health information: Female patient , 85 years of age, was diagnosed with infection (What is infection?) and. Cortancyl dosage: . During the same period patient was treated with CLAFORAN (View Claforan Review and Claforan Label ), OFLOCET /00731801/ (View Oflocet /00731801/ Review and Oflocet /00731801/ Label ), FLAGYL (View Flagyl Review and Flagyl Label ), RULID (View Rulid Review and Rulid Label ), ENDOXAN (View Endoxan Review and Endoxan Label ), UROMITEXAN (View Uromitexan Review and Uromitexan Label ), BACTRIM (View Bactrim Review and Bactrim Label ), AUGMENTIN '125' (View Augmentin '125' Review and Augmentin '125' Label ). Patient was hospitalized.

5806157-X | Diverticular Perforation, Septic Shock
Adverse event was reported on Jun 30, 2008 by a Male patient taking Cortancyl (View Usage) (Dosage: ) . Location: , 49 years of age, Patient experienced the following unwanted or unexpected effects: diverticular perforation, septic shock. During the same period patient was treated with PROFENID (View Profenid Review and Profenid Label ), ARAVA (View Arava Review and Arava Label ), REMICADE (View Remicade Review and Remicade Label ), INIPOMP /01263201/ (View Inipomp /01263201/ Review and Inipomp /01263201/ Label ), COZAAR (View Cozaar Review and Cozaar Label ).

5727191-4 | Complications Of Transplant Surgery, Disease Progression, Disseminated Intravascular Coagulation, Lung Infection, Oesophageal Haemorrhage, Osteitis, Urinary Tract Infection
on Apr 30, 2008 Female patient from FRANCE , 66 years of age, weighting 151.5 lb, was diagnosed with renal transplant and was treated with Cortancyl (View Usage). Patient had the following side effects: complications of transplant surgery, disease progression, disseminated intravascular coagulation, lung infection, oesophageal haemorrhage, osteitis, urinary tract infection (What is urinary tract infection?). Cortancyl dosage: . During the same period patient was treated with CERTICAN (1 Mg / Day) (View Certican Review and Certican Label ), NEORAL (View Neoral Review and Neoral Label ), SOLU MEDROL (View Solu-medrol Review and Solu-medrol Label ). Patient was hospitalized.

5600281-2 | Arthritis, Osteonecrosis
on Jan 11, 2008 Male patient from , child 10 years of age, weighting 39.68 lb, was treated with Cortancyl (View Usage). After Cortancyl was administered, patient had the following side effects: arthritis (What is arthritis?), osteonecrosis (What is osteonecrosis?). Cortancyl dosage: . During the same period patient was treated with SECTRAL (View Sectral Review and Sectral Label ), LASILIX /00032601/ (View Lasilix /00032601/ Review and Lasilix /00032601/ Label ), IMUREL /00001501/ (View Imurel /00001501/ Review and Imurel /00001501/ Label ), ADALAT (View Adalat Review and Adalat Label ), LOPRIL /00498401/ (View Lopril /00498401/ Review and Lopril /00498401/ Label ). Patient was hospitalized.

5577660-5 | Complications Of Transplant Surgery, Disease Progression, Disseminated Intravascular Coagulation, Oesophageal Haemorrhage
Patient was taking Cortancyl (View Usage). Patient experienced the following unwanted or unexpected effects: complications of transplant surgery, disease progression, disseminated intravascular coagulation, oesophageal haemorrhage on Dec 26, 2007 from FRANCE Additional patient health information: Female patient , 66 years of age, weighting 151.5 lb, was diagnosed with renal transplant and. Cortancyl dosage: . During the same period patient was treated with CERTICAN (1 Mg / Day) (View Certican Review and Certican Label ), NEORAL (View Neoral Review and Neoral Label ), SOLU MEDROL (View Solu-medrol Review and Solu-medrol Label ). Patient was hospitalized.

5451540-8 | Hepatitis, Herpes Virus Infection
Adverse event was reported on Sep 03, 2007 by a Male patient taking Cortancyl (View Usage) (Dosage: ) was diagnosed with systemic lupus erythematosus and. Location: FRANCE , 57 years of age, Patient had the following side effects: hepatitis (What is hepatitis?), herpes virus infection. During the same period patient was treated with METHOTREXATE (Unk) (View Methotrexate Review and Methotrexate Label ), PLAQUENIL (400 Mg) (View Plaquenil Review and Plaquenil Label ), METHYLPREDNISOLONE 16MG TAB (View Methylprednisolone 16mg Tab Review and Methylprednisolone 16mg Tab Label ). Patient was hospitalized.

5304391-9 | Lymphoma
on Apr 17, 2007 Female patient from , 71 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Cortancyl (View Usage). After Cortancyl was administered, patient had the following side effects: lymphoma (What is lymphoma?). Cortancyl dosage: . During the same period patient was treated with LASILIX /00032601/ (View Lasilix /00032601/ Review and Lasilix /00032601/ Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), PREVISCAN /00789001/ (View Previscan /00789001/ Review and Previscan /00789001/ Label ), REMICADE (View Remicade Review and Remicade Label ), CALCIPRAT (View Calciprat Review and Calciprat Label ), XALATAN (View Xalatan Review and Xalatan Label ). Patient was hospitalized.

5292269-9 | Erythema Multiforme
on Apr 03, 2007 Male patient from FRANCE , 27 years of age, was diagnosed with systemic lupus erythematosus and was treated with Cortancyl (View Usage). Patient experienced the following unwanted or unexpected effects: erythema multiforme. Cortancyl dosage: . During the same period patient was treated with PLAQUENIL (400 Mg) (View Plaquenil Review and Plaquenil Label ). Patient was hospitalized.

5238224-6 | Infection, Osteitis, Osteonecrosis, Wound Debridement
Patient was taking Cortancyl (View Usage). Patient had the following side effects: infection (What is infection?), osteitis, osteonecrosis (What is osteonecrosis?), wound debridement on Feb 02, 2007 from FRANCE Additional patient health information: Female patient , 76 years of age, was diagnosed with breast cancer metastatic, metastases to bone and. Cortancyl dosage: 20 Mg Daily. During the same period patient was treated with ZOMETA (4 Mg, Qmo) (View Zometa Review and Zometa Label ).

5224301-2 | Malignant Neoplasm Progression, Nephrotic Syndrome, Renal Failure
Adverse event was reported on Jan 23, 2007 by a Female patient taking Cortancyl (View Usage) (Dosage: 20 Mg, Daily (1/d)) was diagnosed with pancreatic carcinoma metastatic and. Location: FRANCE , 60 years of age, weighting 152.1 lb, After Cortancyl was administered, patient had the following side effects: malignant neoplasm progression, nephrotic syndrome, renal failure. During the same period patient was treated with SKENAN (Unk, Unk) (View Skenan Review and Skenan Label ), GEMZAR (1700 Mg, Other) (View Gemzar Review and Gemzar Label ). Patient was hospitalized.

5224045-7 | Infection, Osteitis, Osteonecrosis, Wound Debridement
on Jan 22, 2007 Female patient from FRANCE , 76 years of age, was diagnosed with breast cancer metastatic, metastases to bone and was treated with Cortancyl (View Usage). Patient experienced the following unwanted or unexpected effects: infection (What is infection?), osteitis, osteonecrosis (What is osteonecrosis?), wound debridement. Cortancyl dosage: 20 Mg Daily. During the same period patient was treated with ZOMETA (4 Mg, Qmo) (View Zometa Review and Zometa Label ).

5223801-9 | Infection, Osteitis, Osteonecrosis, Wound Debridement
on Jan 22, 2007 Female patient from FRANCE , 76 years of age, was diagnosed with breast cancer metastatic, metastases to bone and was treated with Cortancyl (View Usage). Patient had the following side effects: infection (What is infection?), osteitis, osteonecrosis (What is osteonecrosis?), wound debridement. Cortancyl dosage: 20 Mg Daily. During the same period patient was treated with ZOMETA (4 Mg, Qmo) (View Zometa Review and Zometa Label ).

5221650-9 | Gingival Infection, Osteonecrosis, Pain In Jaw, Purulent Discharge
Patient was taking Cortancyl (View Usage). After Cortancyl was administered, patient had the following side effects: gingival infection, osteonecrosis (What is osteonecrosis?), pain in jaw, purulent discharge on Jan 16, 2007 from FRANCE Additional patient health information: Female patient , 53 years of age, was diagnosed with metastases to bone and. Cortancyl dosage: . During the same period patient was treated with TAXOTERE (View Taxotere Review and Taxotere Label ), ZOMETA (View Zometa Review and Zometa Label ).

5177498-7 | Coronary Artery Disease, Dyspnoea
Adverse event was reported on Oct 16, 2006 by a Female patient taking Cortancyl (View Usage) (Dosage: ) was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?), osteoarthritis (What is osteoarthritis?), osteoporosis (What is osteoporosis?) and. Location: FRANCE , 75 years of age, Patient experienced the following unwanted or unexpected effects: coronary artery disease (What is coronary artery disease?), dyspnoea. During the same period patient was treated with ART 50 (1 D/f, Daily (1/d)) (View Art 50 Review and Art 50 Label ), FIXICAL VITAMINE D3 (View Fixical Vitamine D3 Review and Fixical Vitamine D3 Label ), FORTEO (20 Ug, Daily (1/d)) (View Forteo Review and Forteo Label ). Patient was hospitalized.

5153787-7 | Hypotension, Pyrexia, Rash Morbilliform, Rash Pruritic, Toxic Skin Eruption
on Nov 07, 2006 Male patient from FRANCE , 56 years of age, was diagnosed with hepatitis b (What is hepatitis b?), bursitis (What is bursitis?) and was treated with Cortancyl (View Usage). Patient had the following side effects: hypotension, pyrexia, rash morbilliform, rash pruritic, toxic skin eruption. Cortancyl dosage: . During the same period patient was treated with OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), HEPSERA (View Hepsera Review and Hepsera Label ), CLAMOXYL (View Clamoxyl Review and Clamoxyl Label ), CARDENSIEL (View Cardensiel Review and Cardensiel Label ), CACIT D3 (View Cacit D3 Review and Cacit D3 Label ), ZEFFIX (View Zeffix Review and Zeffix Label ), TAREG (View Tareg Review and Tareg Label ). Patient was hospitalized.

5139987-0 | Dyspnoea, Interstitial Lung Disease
on Jul 17, 2006 Male patient from , 68 years of age, was treated with Cortancyl (View Usage). After Cortancyl was administered, patient had the following side effects: dyspnoea, interstitial lung disease. Cortancyl dosage: . During the same period patient was treated with SPECIAFOLDINE (View Speciafoldine Review and Speciafoldine Label ), LASILIX /00032601/ (View Lasilix /00032601/ Review and Lasilix /00032601/ Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), VOLTAREN (View Voltaren Review and Voltaren Label ), NOVATREX /00113801/ (View Novatrex /00113801/ Review and Novatrex /00113801/ Label ). Patient was hospitalized.

5139986-9 | Condition Aggravated, Hypoxia, Pulmonary Fibrosis, Respiratory Failure, Somnolence, Superinfection Lung
Patient was taking Cortancyl (View Usage). Patient experienced the following unwanted or unexpected effects: condition aggravated, hypoxia, pulmonary fibrosis (What is pulmonary fibrosis?), respiratory failure, somnolence, superinfection lung on Nov 15, 2004 from Additional patient health information: Female patient , 75 years of age, . Cortancyl dosage: . During the same period patient was treated with HUMIRA (View Humira Review and Humira Label ), IMUREL (View Imurel Review and Imurel Label ), LASILIX /00032601/ (View Lasilix /00032601/ Review and Lasilix /00032601/ Label ), ADALATE 20 MG LP (View Adalate 20 Mg Lp Review and Adalate 20 Mg Lp Label ), ASPEGIC /00002703/ (View Aspegic /00002703/ Review and Aspegic /00002703/ Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ). Patient was hospitalized and became disabled.

5111621-5 | Alanine Aminotransferase Increased, Anuria, Aspartate Aminotransferase Increased, C-reactive Protein Increased, Calculus Urinary, Chills, Cytolytic Hepatitis, Diarrhoea, Dysuria
Adverse event was reported on Sep 08, 2006 by a Male patient taking Cortancyl (View Usage) (Dosage: ) was diagnosed with dermatomyositis and. Location: FRANCE , child 7 years of age, Patient had the following side effects: alanine aminotransferase increased, anuria, aspartate aminotransferase increased, c-reactive protein increased, calculus urinary, chills, cytolytic hepatitis, diarrhoea, dysuria. During the same period patient was treated with FERROSTRANE (View Ferrostrane Review and Ferrostrane Label ), FONCITRIL 4000 (View Foncitril 4000 Review and Foncitril 4000 Label ), FUCIDINE CAP (View Fucidine Cap Review and Fucidine Cap Label ), ESOMEPRAZOLE MAGNESIUM (View Esomeprazole Magnesium Review and Esomeprazole Magnesium Label ), BACTRIM (View Bactrim Review and Bactrim Label ), DOLIPRANE (View Doliprane Review and Doliprane Label ), TACROLIMUS (View Tacrolimus Review and Tacrolimus Label ), AREDIA (Unk, Unk) (View Aredia Review and Aredia Label ). Patient was hospitalized.

5105425-7 | Alanine Aminotransferase Increased, Anuria, Aspartate Aminotransferase Increased, C-reactive Protein Increased, Calculus Urinary, Chills, Cytolytic Hepatitis, Diarrhoea, Dysuria
on Sep 08, 2006 Male patient from FRANCE , child 7 years of age, was diagnosed with dermatomyositis and was treated with Cortancyl (View Usage). After Cortancyl was administered, patient had the following side effects: alanine aminotransferase increased, anuria, aspartate aminotransferase increased, c-reactive protein increased, calculus urinary, chills, cytolytic hepatitis, diarrhoea, dysuria. Cortancyl dosage: . During the same period patient was treated with FERROSTRANE (View Ferrostrane Review and Ferrostrane Label ), FONCITRIL 4000 (View Foncitril 4000 Review and Foncitril 4000 Label ), FUCIDINE CAP (View Fucidine Cap Review and Fucidine Cap Label ), ESOMEPRAZOLE MAGNESIUM (View Esomeprazole Magnesium Review and Esomeprazole Magnesium Label ), BACTRIM (View Bactrim Review and Bactrim Label ), DOLIPRANE (View Doliprane Review and Doliprane Label ), TACROLIMUS (View Tacrolimus Review and Tacrolimus Label ), AREDIA (View Aredia Review and Aredia Label ). Patient was hospitalized.

5059449-9 | Dyspnoea, Interstitial Lung Disease
on Jul 17, 2006 Male patient from , 68 years of age, was treated with Cortancyl (View Usage). Patient experienced the following unwanted or unexpected effects: dyspnoea, interstitial lung disease. Cortancyl dosage: . During the same period patient was treated with SPECIAFOLDINE (View Speciafoldine Review and Speciafoldine Label ), LASILIX (View Lasilix Review and Lasilix Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), VOLTAREN (View Voltaren Review and Voltaren Label ), NOVATREX ^LEDERLE^ (View Novatrex ^lederle^ Review and Novatrex ^lederle^ Label ). Patient was hospitalized.

5033108-0 | Blood Creatinine Increased, Blood Urea Increased, Blood Uric Acid Increased, Glomerulonephritis Minimal Lesion, Hyperphosphataemia, Hypertension, Microcytic Anaemia, Proteinuria, Renal Failure
Patient was taking Cortancyl (View Usage). Patient had the following side effects: blood creatinine increased, blood urea increased, blood uric acid increased, glomerulonephritis minimal lesion, hyperphosphataemia, hypertension, microcytic anaemia, proteinuria, renal failure on Jun 02, 2006 from FRANCE Additional patient health information: Female patient , 39 years of age, was diagnosed with renal transplant and. Cortancyl dosage: 10 Mg Daily. During the same period patient was treated with NEORAL (100 Mg, Bid) (View Neoral Review and Neoral Label ). Patient was hospitalized.

5025664-3 | Blood Creatinine Increased, Blood Urea Increased, Blood Uric Acid Increased, Glomerulonephritis Minimal Lesion, Hyperphosphataemia, Hypertension, Microcytic Anaemia, Proteinuria, Renal Failure
Adverse event was reported on Jun 02, 2006 by a Female patient taking Cortancyl (View Usage) (Dosage: 10 Mg Daily) was diagnosed with renal transplant and. Location: FRANCE , 39 years of age, After Cortancyl was administered, patient had the following side effects: blood creatinine increased, blood urea increased, blood uric acid increased, glomerulonephritis minimal lesion, hyperphosphataemia, hypertension, microcytic anaemia, proteinuria, renal failure. During the same period patient was treated with NEORAL (100 Mg, Bid) (View Neoral Review and Neoral Label ). Patient was hospitalized.

4999320-1 | Cataract, Condition Aggravated, Optic Neuritis
on May 02, 2006 Male patient from , 81 years of age, was diagnosed with pulmonary tuberculosis and was treated with Cortancyl (View Usage). Patient experienced the following unwanted or unexpected effects: cataract (What is cataract?), condition aggravated, optic neuritis. Cortancyl dosage: . During the same period patient was treated with RIFAMPIN AND ISONIAZID (View Rifampin And Isoniazid Review and Rifampin And Isoniazid Label ), LEVOTHYROX (View Levothyrox Review and Levothyrox Label ), PREVISCAN (View Previscan Review and Previscan Label ), MYAMBUTOL (View Myambutol Review and Myambutol Label ), CORDARONE (View Cordarone Review and Cordarone Label ), MODOPAR (View Modopar Review and Modopar Label ), CACIT (View Cacit Review and Cacit Label ).

4984312-9 | Epstein-barr Virus Infection, Hodgkin's Disease, Liver Transplant Rejection, Multi-organ Failure
on Apr 24, 2006 Male patient from FRANCE , 17 years of age, weighting 101.4 lb, was diagnosed with liver transplant (What is liver transplant?) and was treated with Cortancyl (View Usage). Patient had the following side effects: epstein-barr virus infection, hodgkin's disease (What is hodgkin's disease?), liver transplant rejection, multi-organ failure. Cortancyl dosage: 20 Mg, Bid. During the same period patient was treated with IMUREL (View Imurel Review and Imurel Label ), NEORAL (200 Mg, Bid) (View Neoral Review and Neoral Label ). Patient was hospitalized.

4968867-6 | Clonus, Coma, Convulsion, Disorientation, Headache, Hypertensive Encephalopathy, Visual Disturbance
Patient was taking Cortancyl (View Usage). After Cortancyl was administered, patient had the following side effects: clonus, coma, convulsion, disorientation, headache (What is headache?), hypertensive encephalopathy, visual disturbance on Mar 30, 2006 from FRANCE Additional patient health information: Female patient , child 7 years of age, weighting 55.12 lb, was diagnosed with nephrotic syndrome and. Cortancyl dosage: 25 Mg, Qd. During the same period patient was treated with NEORAL (160 Mg, Qd) (View Neoral Review and Neoral Label ). Patient was hospitalized.

4832709-X | Cytolytic Hepatitis, Pancreatitis Acute
Adverse event was reported on Jul 18, 2005 by a Female patient taking Cortancyl (View Usage) (Dosage: ) . Location: , 22 years of age, Patient experienced the following unwanted or unexpected effects: cytolytic hepatitis, pancreatitis acute. During the same period patient was treated with FLAGYL (View Flagyl Review and Flagyl Label ), IMUREL (View Imurel Review and Imurel Label ), SANDOSTATIN (View Sandostatin Review and Sandostatin Label ), LEVOTHYROX (View Levothyrox Review and Levothyrox Label ), ISOPTIN (View Isoptin Review and Isoptin Label ), EUPRESSYL (View Eupressyl Review and Eupressyl Label ), CORVASAL (View Corvasal Review and Corvasal Label ), SPECIAFOLDINE (View Speciafoldine Review and Speciafoldine Label ). Patient was hospitalized.

4818249-2 | Colitis, Diarrhoea
on Oct 25, 2005 Female patient from , 75 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Cortancyl (View Usage). Patient had the following side effects: colitis, diarrhoea. Cortancyl dosage: . During the same period patient was treated with ARAVA (View Arava Review and Arava Label ), VASTEN (View Vasten Review and Vasten Label ), SELOKEN (View Seloken Review and Seloken Label ), MOPRAL (View Mopral Review and Mopral Label ), STABLON (View Stablon Review and Stablon Label ), SOLU MEDROL (View Solu-medrol Review and Solu-medrol Label ), COUMADIN (View Coumadin Review and Coumadin Label ), SEGLOR (View Seglor Review and Seglor Label ). Patient was hospitalized.

4814923-2 | Diabetes Mellitus, Hypertension
on Oct 24, 2005 Male patient from FRANCE , 68 years of age, weighting 160.9 lb, was diagnosed with photodermatosis and was treated with Cortancyl (View Usage). After Cortancyl was administered, patient had the following side effects: diabetes mellitus, hypertension. Cortancyl dosage: 60 Mg, Qd. During the same period patient was treated with NEORAL (150 Mg, Bid) (View Neoral Review and Neoral Label ). Patient was hospitalized.

4788608-5 | Cytolytic Hepatitis, Pancreatitis Acute
Patient was taking Cortancyl (View Usage). Patient experienced the following unwanted or unexpected effects: cytolytic hepatitis, pancreatitis acute on Jul 18, 2005 from Additional patient health information: Female patient , 22 years of age, . Cortancyl dosage: . During the same period patient was treated with FLAGYL (View Flagyl Review and Flagyl Label ), IMUREL (View Imurel Review and Imurel Label ), SANDOSTATIN (View Sandostatin Review and Sandostatin Label ), LEVOTHYROX (View Levothyrox Review and Levothyrox Label ), ISOPTIN (View Isoptin Review and Isoptin Label ), EUPRESSYL (View Eupressyl Review and Eupressyl Label ), CORVASAL (View Corvasal Review and Corvasal Label ), SPECIAFOLDINE (View Speciafoldine Review and Speciafoldine Label ). Patient was hospitalized.

4777388-5 | Agitation, Ammonia Increased, Creatinine Renal Clearance Decreased, Depressed Level Of Consciousness, Hepatic Encephalopathy, Incoherent, Intubation
Adverse event was reported on Sep 15, 2005 by a Male patient taking Cortancyl (View Usage) (Dosage: 50 Mg, Qod) was diagnosed with antibiotic prophylaxis, liver transplant (What is liver transplant?) and. Location: FRANCE , 14 years of age, weighting 79.37 lb, Patient had the following side effects: agitation, ammonia increased, creatinine renal clearance decreased, depressed level of consciousness, hepatic encephalopathy, incoherent, intubation. During the same period patient was treated with CIFLOX (250 Mg, Tid) (View Ciflox Review and Ciflox Label ), NEORAL (60 Mg, Bid) (View Neoral Review and Neoral Label ). Patient was hospitalized.

4775563-7 | Squamous Cell Carcinoma
on Sep 13, 2005 Female patient from , 49 years of age, weighting 110.2 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Cortancyl (View Usage). After Cortancyl was administered, patient had the following side effects: squamous cell carcinoma. Cortancyl dosage: . During the same period patient was treated with ARAVA (View Arava Review and Arava Label ), ENBREL (View Enbrel Review and Enbrel Label ), HUMIRA (View Humira Review and Humira Label ).

4758935-6 | Cholelithiasis, Cytolytic Hepatitis, Pancreatitis Acute
on Jul 18, 2005 Female patient from , 22 years of age, was treated with Cortancyl (View Usage). Patient experienced the following unwanted or unexpected effects: cholelithiasis, cytolytic hepatitis, pancreatitis acute. Cortancyl dosage: . During the same period patient was treated with FLAGYL (View Flagyl Review and Flagyl Label ), IMUREL (View Imurel Review and Imurel Label ), SANDOSTATIN (View Sandostatin Review and Sandostatin Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), ISOPTIN (View Isoptin Review and Isoptin Label ), EUPRESSYL (View Eupressyl Review and Eupressyl Label ), CORVASAL (View Corvasal Review and Corvasal Label ), SPECIAFOLDINE (View Speciafoldine Review and Speciafoldine Label ). Patient was hospitalized.

4725021-0 | Cholelithiasis, Cytolytic Hepatitis, Pancreatitis Acute
Patient was taking Cortancyl (View Usage). Patient had the following side effects: cholelithiasis, cytolytic hepatitis, pancreatitis acute on Jul 18, 2005 from Additional patient health information: Female patient , 22 years of age, . Cortancyl dosage: . During the same period patient was treated with FLAGYL (View Flagyl Review and Flagyl Label ), IMUREL (View Imurel Review and Imurel Label ), SANDOSTATIN (View Sandostatin Review and Sandostatin Label ), LEVOTHYROX (View Levothyrox Review and Levothyrox Label ), ISOPTIN (View Isoptin Review and Isoptin Label ), EUPRESSYL (View Eupressyl Review and Eupressyl Label ), CORVASAL (View Corvasal Review and Corvasal Label ), SPECIAFOLDINE (View Speciafoldine Review and Speciafoldine Label ). Patient was hospitalized.

4702936-0 | Coma, Confusional State, Convulsion, Encephalopathy
Adverse event was reported on Jun 21, 2005 by a Male patient taking Cortancyl (View Usage) (Dosage: ) . Location: , 50 years of age, After Cortancyl was administered, patient had the following side effects: coma, confusional state, convulsion, encephalopathy. During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ), NEORAL (View Neoral Review and Neoral Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ).

4693040-9 | Interstitial Lung Disease
on Jun 10, 2005 Female patient from , 62 years of age, weighting 136.7 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Cortancyl (View Usage). Patient experienced the following unwanted or unexpected effects: interstitial lung disease. Cortancyl dosage: 8 Mg/day. During the same period patient was treated with ESTRADERM (1 Df, Qw2) (View Estraderm Review and Estraderm Label ), NOVATREX (10 Mg/week) (View Novatrex Review and Novatrex Label ), REMICADE (Courses Of 200 Mg/day) (View Remicade Review and Remicade Label ), SPECIAFOLDINE (10 Mg/week) (View Speciafoldine Review and Speciafoldine Label ), DUPHASTON (10 Mg, Qd) (View Duphaston Review and Duphaston Label ). Patient was hospitalized.